imipramine and mdl 100907

imipramine has been researched along with mdl 100907 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carretero, M; Díaz-Ricart, M; Escolar, G; Gastó, C; Gómez-Gil, E; Navinés, R; Salamero, M1
Bertaina-Anglade, V; Boyer, PA; la Rochelle, CD; Mocaër, E1
Hutson, PH; Murray, F1
Filip, M; McCreary, AC; Wydra, K; Zaniewska, M1
Vicente, MA; Zangrossi, H1

Trials

1 trial(s) available for imipramine and mdl 100907

ArticleYear
Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression.
    Human psychopharmacology, 2004, Volume: 19, Issue:4

    Topics: Adult; Antidepressive Agents, Tricyclic; Blood Platelets; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Imipramine; Male; Platelet Aggregation; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists

2004

Other Studies

4 other study(ies) available for imipramine and mdl 100907

ArticleYear
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.
    Behavioural pharmacology, 2006, Volume: 17, Issue:8

    Topics: Acetamides; Aminopyridines; Animals; Antidepressive Agents; Avoidance Learning; Helplessness, Learned; Imipramine; Indoles; Male; Melatonin; Rats; Rats, Wistar; Receptors, Melatonin; Serotonin 5-HT2 Receptor Antagonists; Thiophenes

2006
Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
    European journal of pharmacology, 2007, Aug-13, Volume: 569, Issue:1-2

    Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Citalopram; Fluorobenzenes; Hippocampus; Imipramine; Indoles; Male; Mice; Piperazines; Piperidines; Proto-Oncogene Proteins c-bcl-2; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides

2007
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
    Neuropharmacology, 2010, Volume: 58, Issue:7

    Topics: Animals; Antidepressive Agents, Tricyclic; Depression; Imipramine; Male; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome; Swimming; Time Factors; Treatment Outcome

2010
Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:3

    Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Avoidance Learning; Basolateral Nuclear Complex; Exploratory Behavior; Fluoxetine; Imipramine; Indoles; Male; Maze Learning; Neuropsychological Tests; Pyrazines; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists

2012